Trualt Bioenergy IPO Details

MAINBOARD NSE BSE

Trualt Bioenergy IPO Summary

Trualt Bioenergy Logo | Trualt Bioenergy IPO Details, Date, Price, GMP, Live Subscription

Trualt Bioenergy IPO opens for subscription on 25 Sep 2025 and closes on 29 Sep 2025.The IPO will be listed on NSE, BSE with the tentative listing date set for 03 Oct 2025.

Trualt Bioenergy IPO price band has been fixed at ₹472 – ₹496 per share. The face value is ₹10 per share with a lot size of 30.

Trualt Bioenergy IPO total issue size comprises 1,69,20,968 shares (aggregating up to ₹839.28 Cr). This includes a fresh issue of 1,51,20,968 shares (aggregating up to ₹750.00 Cr). Offer for Sale consists of 18,00,000 shares (aggregating up to ₹89.28 Cr).

Trualt Bioenergy IPO carries a ₹85 (17.14%) GMP, reflecting investor sentiment.

Trualt Bioenergy IPO Lot Size :Retail Minimum is 1 lot (30 shares) amounting to ₹14,880. Retail Maximum is 13 lots (390 shares) amounting to ₹193,440. SHNI Minimum is 14 lots (420 shares) amounting to ₹208,320. SHNI Maximum is 67 lots (2,010 shares) amounting to ₹996,960. BHNI Minimum is 68 lots (2,040 shares) amounting to ₹1,011,840.

The Lead Managers for Trualt Bioenergy IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Dam Capital Advisors Ltd, SBI Capital Markets Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Trualt Bioenergy Limited RHP.

Trualt Bioenergy IPO Details

Listing Price : ₹545.4 at a Premium of 9.96%
Open Date
25 Sep 2025
Close Date
29 Sep 2025
Listing Date
03 Oct 2025
Issue Price
₹472 - ₹496
Face Value
₹10 per share
Lot Size
30 Shares
GMP
₹85(17.14%)
Issue Type
IPO
Listing On
NSE, BSE
Type
Book Built Issue
Pre-issue Shareholding
7,06,31,624 shares
Post-issue Shareholding
-
Total Issue Size
1,69,20,968 shares(aggregating up to ₹839.28 Cr)
Fresh Issue
1,51,20,968 shares(aggregating up to ₹750.00 Cr)
Offer for Sale
18,00,000 shares(aggregating up to ₹89.28 Cr)

Trualt Bioenergy IPO Subscription

Trualt Bioenergy IPO Application Wise Breakup (Approx)

Trualt Bioenergy IPO Dates

  • 25 Sep 2025
    Opening dateOpen
  • 29 Sep 2025
    Closing dateClose
  • 30 Sep 2025
    Allotment Date Allotment
  • 01 Oct 2025
    Initiation of RefundsRefund
  • 01 Oct 2025
    Credit of SharesCredit
  • 03 Oct 2025
    Listing dateListing

Trualt Bioenergy IPO Lot Size

ApplicationLotsSharesAmount
Retail Minimum130₹14,880
Retail Maximum13390₹193,440
SHNI Minimum14420₹208,320
SHNI Maximum672010₹996,960
BHNI Minimum682040₹1,011,840

Trualt Bioenergy IPO Reservation

Promoter Holding

Pre Issue:
88.20%
Post Issue:
70.55%
Promoter Names:
Vijaykumar Murugesh Nirani, Vishal Nirani, Sushmitha Vijaykumar Nirani

Trualt Bioenergy IPO Valuations

ROE28.27%
ROCE10.88%
DEBT/EQUITY2.02
RONW19.07%
PAT MARGIN7.69%
PRICE TO BOOK VALUE4.56
P/E Pre IPO23.89
P/E Post IPO29.01

Trualt Bioenergy Financial Information

Period Ended31 Mar 202531 Mar 2024
Assets3,029.732,419.08
Total Income1,968.531,280.19
Profit After Tax146.6431.81
EBITDA309.14188.09
NET Worth769.00264.61
Total Borrowing1,549.681,684.68
Amount in ₹ Crore

About Trualt Bioenergy IPO

Trualt Bioenergy Limited, incorporated in 2021, is engaged in the production of biofuels, with a primary focus on the ethanol sector. It is one of the largest Ethanol producer in India based on installed capacity of 2,000 kilo litres per day (KLPD). In Fiscal 2025, it has a 3.6% market share in ethanol production capacity.

The company's business operations spans across ethanol production and compressed biogas (CBG) production. As on Mar 31, 2025, its subsidiary, Leafinity operates one CBG production plan with a capacity of 10.20 TPD (Tonnes per day). To further expand its CBG capacity, it has entered into Memorandum of understandings (MoUs) with a Japanese Gas company and Sumitomo Corporation Asia & Oceania Pte. Ltd.

As on the date of RHP, the company has five distillery units in Karnataka, four are operated on molasses and syrup-based feedstocks.

The company also proposed to enter into other verticals, including second-generation ethanol, sustainable aviation fuel, and Mevalonolactone (“MVL”) and Allied Biochemicals.

 

Strength Of Trualt Bioenergy IPO

1. Largest installed capacity for production of ethanol in India.

2. Assured supply of key raw materials and utilities.

3. Scalable and vertically integrated biofuels player.

4. Rapid scale up with multiple CBG plants, positioning ourselves among India's leading producers of CBG/Bio-CNG.

5. Ethanol to SAF: Towards one of the world's largest facilities.

6. Recognition as a private OMC: Expanding into Direct-to-Consumer Biofuel Retail.

7. Partnerships for Progress: Expanding through Strategic Partnerships and Acquisitions.

8. Advanced production infrastructure with a focus on technological innovation and sustainability.

9. Well-positioned to capture favourable industry tailwinds.

10. Entrenched customer relationships, creating a strong demand pipeline.

Risk Of Trualt Bioenergy IPO

1. Our business is currently primarily dependent on the sale of ethanol. Any reduction in the sale of ethanol, or our ability to produce and sell ethanol, or in the price at which we are able to sell ethanol, may have an adverse effect on our business, results of operations, cash flows and financial condition.

2. Our business is substantially dependent on the policies of the Government of India ("GoI"). Any change in GoI policies in this regard could have an impact on our revenue, results of operations and financial condition.

3. Our Company has a limited operating history, as our Company commenced ethanol production pursuant to business transfer agreements in September 2022. We may be subject to liabilities and other risks arising out of the business transfer agreements, and we may not be able to derive the anticipated benefits from these acquisitions.

4. Our erstwhile group companies have made certain allotments of Equity Shares where the allotment was made to more than 49 persons, which have been compounded pursuant to compounding application filed by our Group Company before the National Company Law Tribunal, Bengaluru bench. Our Group Company had also filed a settlement application with the Securities and Exchange Board of India, and a settlement order has been passed with regard to any proceedings that may be initiated in respect of this matter.

5. We derive a significant portion of our revenue from a few customers, in particular oil marketing companies ("OMCs"). The loss of one or more such customers, or a reduction in their demand for our products may adversely affect our business, results of operations, financial condition and cash flows.

6. Under-utilization of our existing production capacities and an inability to effectively utilize our expanded production capacities could have an adverse effect on our business, future prospects and future financial performance.

7. We have entered into supply contracts with one member of our Promoter Group, and MRN Bhima Sugar and Power Private Limited and MRN Canepower and Biorefineries Private Limited for supply of a significant portion of our raw material requirements. Any termination of such contracts, failure to renew such contracts on favourable terms or at all, or non-performance of obligations under such contracts, may impact our business, financial condition, cash flows and results of operations.

8. Our ethanol production depends on the availability of raw material such as sugar syrup/juice and molasses, and any alternatives we may require in future, such as grains and biomass. Any shortage of sugarcane, the underlying raw material, which is subject to seasonal vagaries, adverse weather conditions, crop disease and pest attacks, may impact the availability and quality of our key raw materials, which may have an adverse impact on our business, financial condition and results of operations.

9. Our inability to accurately forecast demand for our products, manage our working capital balances, or our inability to collect receivables in a timely manner may have an adverse effect on our business, results of operations, cash flows and financial condition.

10. We are subject to strict quality requirements, and sale of our products is dependent on our quality controls and standards. Any failure to comply with quality standards may adversely affect our business prospects and financial performance.

Objectives Trualt Bioenergy IPO

1. Funding capital expenditure towards setting- up multi-feed stock operations to pave- way for utilizing grains as an additional raw material in ethanol plant at TBL Unit 4 of 300 KLPD capacity.

2. Funding our working capital requirements.

3. General corporate purposes

Company Contact Details

Trualt Bioenergy Ltd.
Survey No. 166, Kulali Cross,
Jamkhandi Mudhol Road, Bagalkot,
587313, Karnataka, India
Bagalkot, Karnataka, 587313
Phone: 080 2325 5000
Email: cs@trualtbioenergy.com
Website: https://www.trualtbioenergy.com/

Registrar Contact Details

Name:
Bigshare Services Pvt Ltd
Phone:
+91-22-62638200

Trualt Bioenergy FAQs

The Trualt Bioenergy IPO is a MAINBOARD public issue comprising 16920968 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹839.28 Cr. The issue price has been fixed at ₹496 per equity share, and the minimum application size is 30 shares.

The IPO opens for subscription on 25 Sep 2025, and closes on 29 Sep 2025.

Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

The Trualt Bioenergy IPO opens on 25 Sep 2025.

Trualt Bioenergy IPO lot size is 30, and the minimum amount required for application is ₹14880.

You may apply for the Trualt Bioenergy IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Trualt Bioenergy IPO is scheduled to be finalized on 30 Sep 2025. Subsequently, the shares allotted will be credited to investors’ demat accounts by 01 Oct 2025. Investors are advised to regularly check the Trualt Bioenergy IPO allotment status for updates.

The listing date for the Trualt Bioenergy IPO has not yet been officially announced. However, the tentative listing date is scheduled for 03 Oct 2025.

Trualt Bioenergy IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at ₹85 (17.14%).

Comments

Download A2ZIPO App for Live IPO Subscription and GMPA2ZIPO - Get Latest Mainboard and SME IPO Details